- |||||||||| RPh201 / Regenera
Trial completion date, Trial suspension, Trial primary completion date: The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study (clinicaltrials.gov) - Feb 6, 2018 P1, N=10, Suspended, Recruiting --> Suspended | Trial primary completion date: Jan 2017 --> Jan 2019 | Trial completion date: Oct 2018 --> Oct 2020
- |||||||||| Phase classification: tDCS in MCS: Repeated Stimulations (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=20, Completed, Trial primary completion date: Dec 2016 --> Dec 2018 Phase classification: P2 --> P=N/A
- |||||||||| RPh201 / Regenera
Enrollment change, Trial withdrawal, Trial primary completion date: The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements (clinicaltrials.gov) - Sep 22, 2015 P1/2, N=0, Withdrawn, Trial primary completion date: Jan 2014 --> Jan 2017 N=10 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Oct 2013 --> Oct 2017
- |||||||||| Trial completion, Trial primary completion date: Transcranial Brain Stimulation in Vegetative State Patients (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=40, Completed, Trial primary completion date: May 2015 --> Mar 2016 Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Dec 2014
- |||||||||| Trial completion, Trial primary completion date: tDCS in MCS: Repeated Stimulations (clinicaltrials.gov) - Oct 24, 2014
P2, N=20, Completed, Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Sep 2014
- |||||||||| NN1213 / Novo Nordisk
Trial completion: A Study to Tailor Advance Directives (clinicaltrials.gov) - Feb 22, 2014 P=N/A, N=100, Completed, Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Sep 2014 No longer recruiting --> Completed
|